التفاصيل البيبلوغرافية
| العنوان: |
Complete Hematological Remission after Decitabine Treatment in a Patient with Congenital Agammaglobulinemia, FLT3- and TP53-Mutated Acute Myeloid Leukemia |
| المؤلفون: |
E, Vigna, D, Caracciolo, E, Martino, F, Mendicino, N, Caruso, C, Botta, R, Morelli, M, Gentile, R, Tenuta, F, Greco |
| المصدر: |
Austin Oncology Case Reports ; volume 4, issue 1 |
| بيانات النشر: |
Austin Publishing Group |
| سنة النشر: |
2021 |
| الوصف: |
Older and unfit patients with Acute Myeloid Leukemia (AML), which are uneligible for standard induction therapy, have limited treatment options. The therapeutic approach in these cases is based on the use of hypomethylating agents, either decitabine or azacitidine, or Low-Dose Cytarabine (LDAC). However, despite the extensive use of these agents, there is no consensus regarding the extent of their efficacy, and clinical benefit deriving from their use is very modest. We present a case of FLT3- and TP53-mutated AML in an unfit patient with congenital agammaglobulinemia, responsive to single agent decitabine, with a response duration of over 20 months. |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
unknown |
| DOI: |
10.26420/austinoncolcaserep.2021.1014 |
| الاتاحة: |
http://dx.doi.org/10.26420/austinoncolcaserep.2021.1014 |
| رقم الانضمام: |
edsbas.714EDD4D |
| قاعدة البيانات: |
BASE |